A few latency genes, expressed in Hodgkin’s lymphoma and nasopharyngeal carcinoma, such as EBNA1, LMP1, and LMP2, represent potential epitopes for the EBV therapeutic vaccine, with which dendritic cells can be transformed [17]. This evidence concerns the gene PSMB9 and nasopharyngeal carcinoma.